Marshall Wace North America’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-8,314
Closed -$339K 1662
2020
Q3
$339K Buy
+8,314
New +$414K ﹤0.01% 1046
2019
Q4
Sell
-104,321
Closed -$5.73M 1685
2019
Q3
$5.73M Buy
+104,321
New +$5.97M 0.03% 342
2019
Q2
Sell
-17,575
Closed -$992K 1728
2019
Q1
$992K Buy
17,575
+10,715
+156% +$639K 0.01% 670
2018
Q4
$438K Buy
+6,860
New +$486K ﹤0.01% 806
2018
Q2
Sell
-9,957
Closed -$386K 1782
2018
Q1
$386K Sell
9,957
-373,278
-97% -$13.1M ﹤0.01% 1214
2017
Q4
$10.7M Buy
+383,235
New +$11.2M 0.06% 365

Other funds holding TRHC

Marshall Wace North America's TRHC Position: Q4 2020 in Review

Marshall Wace North America sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2020, closing a stake of 8,314 shares — an estimated $339K sold.

Marshall Wace North America first reported a position in TRHC in Q4 2017 and held it in 6 quarters. The position peaked at $10.7M in Q4 2017. 163 funds tracked by Wall St. Rank hold TRHC as of Q4 2020.

  • Marshall Wace North America reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 8,314 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2020, an estimated $339K.
  • Marshall Wace North America first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 6 quarters.
  • Marshall Wace North America's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $10.7M in Q4 2017.
  • 163 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.